Verve Therapeutics Wants to Use CRISPR to Fight Heart Disease
Verve’s CRISPR therapy seeks to introduce a helpful genetic mutation to people at risk of heart disease…
Sign-up for hard-hitting research on hot growth stocks, wild new developments, and the inner workings of the high-tech industry. Every weekday at 4:00 pm ET
Verve’s CRISPR therapy seeks to introduce a helpful genetic mutation to people at risk of heart disease…
Clearly, the market is placing an aggressive forward valuation on Nikola…
What makes KOI-456.04 unique is that it orbits a yellow dwarf star that’s very similar to our Sun…
Even if Apple does get this project off the ground in the next five years, it still wouldn’t be...
Only once you’ve built up a strong foundation have you earned the ability to take on more risk…
Light, autonomous aircraft like this could transform the entire aviation landscape…
Thanks for signing up for The Bleeding Edge — we’re glad you’re here!
Want updates sent straight to your phone too? Sign up for SMS alerts to get the latest delivered via text.
Brownstone Research: By submitting your phone number, you agree to our SMS Terms & Conditions, Terms of Use, & Privacy Policy, and give express written consent to receive marketing text messages from BSR. Messages are recurring & frequency may vary. Reply STOP to 94703 to opt out. Reply HELP to 94703 for info. Consent is not a condition of purchase. Message and data rates may apply. For additional information, you may contact Customer Service at 888-512-0726 or smssupport@brownstoneresearch.com.